Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Richard Feachem Discusses Role Of Research, Policy, Private Sector In Malaria Response

Development Policy Centre’s “Devpolicy Blog”: Research, policy and the private sector: Sir Richard Feachem on malaria “…Professor Gabriele Bammer of the National Centre for Epidemiology and Population Health at ANU interviewed Sir Richard [Feachem, director of the Global Health Group at UCSF Global Health Sciences,] on the role of researchers,…

J&J Begins Human Trials Of Experimental Ebola Vaccine

Bloomberg News: J&J Injects First Volunteer in Race to Make Ebola Vaccine “Johnson & Johnson (JNJ) started a trial of its experimental Ebola vaccine in the U.K. and said it will produce two million courses of the shot this year…” (Bennett, 1/6). Reuters: J&J, Bavarian Nordic start clinical tests in…

Devex Examines Roles Of NGOs, Private Companies In Promoting Food Security

Devex: How companies and NGOs can work together to tackle food security “…Toward the end of last year, Devex Impact caught up separately with John Mendesh, General Mills’ vice president of research and development, and Brent Wibberley, director of PFS programs at TechnoServe, to talk to them about the private…

GHIT Fund Helping Pharmaceutical Companies To Develop NTD Treatments

Japan Times: Japanese drugmakers addressing neglected tropical diseases, and not just out of altruism “…A total of one billion people are currently infected with NTDs, a major obstacle to development in poorer countries. To address the problem, the Global Health Innovative Technology (GHIT) Fund, a Japan-initiated organization, assists in the…

Agencies Working To Develop Faster Ebola Diagnostic Tests

VOA News: Better Ebola Tests Expected Within Months “…Health agencies agree there is an urgent need for innovative ways to provide rapid, sensitive, safe, and simple testing. WHO, Doctors Without Borders, and the private organization the Foundation of Innovative New Diagnostics are working with a number of companies to develop…

Private Financial Backing, Strong Coordination Can Help Eliminate NTDs

The Guardian: Pills, philanthropy, and parasitic worms Ellen Agler, chief executive, and Warren Lancaster, senior vice president of program, both at the End Fund “…The global movement to end NTDs has seen significant momentum in recent years. One of the most promising aspects of this is that new partners have…

FCAA Report Examines Philanthropic Funding For HIV/AIDS, Shows Decrease

Funders Concerned About AIDS (FCAA): Philanthropic Support to Address HIV/AIDS in 2013 The latest edition of this annual report from FCAA shows that “[f]unding to address HIV/AIDS from global private philanthropic institutions totaled $592 million in 2012, an 8% decrease from 2012, and the lowest level of funding since 2007”…

GlaxoSmithKline Again Tops ‘Access To Medicine Index’

New York Times: GlaxoSmithKline Leads In Getting Drugs to Poor “For the fourth time, GlaxoSmithKline has led all other pharmaceutical companies on an influential list ranking companies by how effectively they help the world’s poor get needed medicines. The list, the Access to Medicine Index, has been published every other…